Kapil D. Sethi
Georgia Regents University
198 Papers
1.1K Citations
Kapil D. Sethi is an academic researcher from Georgia Regents University. The author has contributed to research in topics: Medicine & Parkinson's disease. The author has an hindex of 51, co-authored 182 publications.
Chat about Author
Papers
Asymmetry in clinical features of drug-induced parkinsonism.
Kapil D. Sethi,Edward Zamrini +1 more
TL;DR: Investigation of asymmetry of signs and symptoms in 20 patients with drug-induced parkinsonism found Tremor was identified in seven patients, slowness in five, and mixed symptoms in eight, a notable asymmetric of signs was seen in six patients.
42
Drug-Induced Movement Disorders
TL;DR: The DIMDs of akathisia, tardive dyskinesia, dystonia, and parkinsonism are reviewed and their epidemiology, mechanism, clinical presentation and differential diagnosis, risk factors, morbidity and mortality, and prevention and management are discussed.
42
Metoclopramide-induced parkinsonism.
TL;DR: Reports of metoclopramide-induced parkinsonism seen in consultation over a two-year period suggest appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.
39
Self-stimulatory behavior associated with deep brain stimulation in Parkinson's disease.
John C. Morgan,John C. Morgan,Caroline J. diDonato,Sanjay S. Iyer,Patrick D. Jenkins,Joseph R. Smith,Kapil D. Sethi +6 more
TL;DR: This work reports a pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson’s disease in subjects of Jewish ethnicity and analysis of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
38
Clinical and Imaging Progression in the PARS Cohort: Long‐Term Follow‐up
Andrew Siderowf,Danna Jennings,Matthew B. Stern,John Seibyl,Shirley Eberly,David Oakes,Kenneth Marek,Ken Marek,David W. Russell,Kapil D. Sethi,Samuel Frank,Tanya Simuni,Robert A. Hauser,Bernard Ravina,Irene Richards,Grace S. Liang,Charles H. Adler,Rachel Saunders-Pullman,Marian L. Evatt,Eugene Lai,Indu Subramanian,Penelope Hogarth,Kathryn A. Chung +22 more
TL;DR: The PARS study was designed to test whether screening for hyposmia followed by dopamine transporter imaging can identify risk for conversion to clinical PD, and to evaluate progression markers during the prodromal period.
38